Ravi I Thadhani
Overview
Explore the profile of Ravi I Thadhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winkelmayer W, Lensing A, Thadhani R, Mahaffey K, Walsh M, Pap A, et al.
Kidney Int
. 2024 Mar;
106(1):145-153.
PMID: 38537676
Patients with kidney failure on hemodialysis (KF-HD) are at high risk for both atherothrombotic events and bleeding. This Phase IIb study evaluated the dose-response of fesomersen, an inhibitor of hepatic...
2.
Tonelli M, Wiebe N, Gill J, Bello A, Hemmelgarn B, Chan C, et al.
Kidney Med
. 2023 Jul;
5(8):100684.
PMID: 37502378
Rationale And Objective: Frailty is common among people with kidney failure treated with hemodialysis (HD). The objective was to describe how frailty evolves over time in people treated by HD,...
3.
Chandra A, Picard M, Huang S, Gupta D, Agusala K, Buring J, et al.
J Am Heart Assoc
. 2022 Oct;
11(21):e025008.
PMID: 36285795
Background Vitamin D supplementation leads to regression of left ventricular (LV) hypertrophy and improves LV function in animal models. However, limited data exist from prospective human studies. We examined whether...
4.
Berg A, Tavasoli M, Lo A, Burnett-Bowie S, Bhan I, Karumanchi S, et al.
PLoS One
. 2021 Jul;
16(7):e0254158.
PMID: 34242315
Background: Bioavailable 25-hydroxyvitamin D (25OHD) may be a better indicator of vitamin D sufficiency than total 25OHD. This report describes a novel assay for measuring serum bioavailable 25OHD. Methods: We...
5.
Olaniran K, Eneanya N, Zhao S, Ofsthun N, Maddux F, Thadhani R, et al.
Am J Nephrol
. 2021 Jan;
51(12):995-1003.
PMID: 33486484
Background: Sickle cell disease (SCD) is the most common inherited hematological disorder and a well-described risk factor for end-stage kidney disease (ESKD). Mortality and hospitalizations among patients with SCD who...
6.
Fader K, Zhang J, Menetski J, Thadhani R, Antman E, Friedman G, et al.
J Pharmacol Exp Ther
. 2020 Oct;
376(1):12-20.
PMID: 33115823
Faced with the health and economic consequences of the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the biomedical community came together to identify, diagnose, prevent, and treat...
7.
Moorthi R, Fadel W, Cranor A, Hindi J, Avin K, Lane K, et al.
Am J Nephrol
. 2020 Aug;
51(9):705-714.
PMID: 32781443
Background: Impaired mobility is associated with functional dependence, frailty, and mortality in prevalent patients undergoing dialysis. We investigated risk factors for mobility impairment, (poor gait speed) in patients incident to...
8.
Lecarpentier E, Zsengeller Z, Salahuddin S, Covarrubias A, Lo A, Haddad B, et al.
Hypertension
. 2020 Jul;
76(3):875-883.
PMID: 32654553
Elevated circulating sFLT-1 (soluble fms-like tyrosine kinase) and low levels of its ligand, PlGF (placental growth factor), are key characteristics of preeclampsia. However, it is unclear if the low levels...
9.
Rhee E, Guallar E, Hwang S, Kim N, Tonelli M, Moe S, et al.
Kidney360
. 2020 Jun;
1(2):86-92.
PMID: 32529191
Background: Uremic symptoms are major contributors to the poor quality of life among patients on dialysis, but whether their prevalence or intensity has changed over time is unknown. Methods: We...
10.
Thadhani R, Rosen S, Ofsthun N, Usvyat L, Dalrymple L, Maddux F, et al.
Clin J Am Soc Nephrol
. 2020 Mar;
15(3):384-391.
PMID: 32111702
Background And Objectives: In the United States, intravenous vitamin D analogs are the first-line therapy for management of secondary hyperparathyroidism in hemodialysis patients. Outside the United States, oral calcitriol (1,25-dihydroxyvitamin...